Euglycemic Diabetic Ketoacidosis after the Initiation of Treatment in a Patient with New-Onset Type 2 Diabetes Mellitus

We report the onset of euglycemic diabetic ketoacidosis (EDKA) in a 20-year-old male patient with new-onset type 2 diabetes mellitus (T2DM) 5 days after initiation diet restriction and combination SGLT2 (sodium–glucose co-transporter 2) inhibitors, glucagon-like peptide 1 receptor agonists, metformin. The use inhibitors symptomatic patients T2DM along extreme reduction carbohydrate intake might trigger EDKA. Judicious, stepwise available therapies strict monitoring can reduce risk this complication.